




POLICY AND PRACTICE UPDATES    
 
Shanghai Health Care Reform Plan Officially Launched  
Source: 21st Century Economic Reporter 2011-5-18 
http://www.21cbh.com/HTML/2011-5-18/3MMDAwMDIzODg3MA.html  
 
After a period of public comments and subsequent amendments, the final version of Shanghai 
Healthcare Reform Plan was officially released on May 17th. Shanghai government set a higher 
goal for itself, promising not only to complete national goals, but to set up a basic healthcare 
network covering urban and rural residents by 2012. 
 
It is worth noting that the plan has two new components. The first one is to reform the 
compensation method for public hospitals. Under the new mechanism, the drug mark-up will be 
abolished and public hospitals will be compensated through pharmaceutical service fees, medical 
service fees for high-end procedures and care, and government investment. The second change is 
to construct vertical regional medical consortiums among primary, secondary and tertiary hospitals 
and community medical centers. The consortiums will increase efficiency of health resources 
utilization. In anticipation of possible profit-sharing problems among medical institutions, Shanghai 
will adopt total budget system within consortiums, an idea borrowed from Zhenjiang, a pioneering 
region in medical reform. 
 
New Cost Containment Policy: Diagnosis-Related Group (DRG) Based Payment Strategy 
Implemented in Major Cities 
Source: 21st Century Economic Reporter 2011-4-27 
http://www.21cbh.com/HTML/2011-4-28/4NMDAwMDIzNTM4Ng.html  
 
Starting on May 1st, several cities and regions in China will implement the Diagnosis-Related Group 
(DRG) Based Payment Strategy to control the rapid increase in medical expenditure, which has 
been partially blamed on the itemized payment system. The reform will hopefully improve the 
quality of medical treatment, ensure medical safety and reduce medical costs. 
 
DRG Based Payment in China is still in its experimental stage and faces many difficulties. For 
example, the new payment strategy should be based on a complete clinical pathway 
management system which is still new in China. The reform also requires realignment of the 
hospitals' interests and reconstruction of the relationship between hospitals and medical insurance 
departments. The cooperation of related departments plays a significant role in this reform that is a 
long-term process requiring at least two or three years. 
 
Diagnosis-Related Group (DRG) Based Payment: Experience from Beijing  
Source: 21st Century Economic Reporter 2011-5-19 
http://www.21cbh.com/HTML/2011-5-19/3NMDAwMDIzOTA3Ng.html  
 
DRG Based Payment will be implemented soon in Beijing, according to an officer of the Bureau of 
Public Health. The purpose of the reform is to control the rapid increase of medical expenditure, 
whose root cause was considered to be the itemized payment system. Under the traditional system, 
physicians have the incentive to prescribe unnecessary procedures or drugs to increase their 
income. The DRG payment system sets a uniform price tag per disease group. Once medical costs 
exceed the price tag, hospitals will be responsible for the balance, providing physicians a strong 
incentive to reduce procedures or drugs prescribed. Conversely, hospitals might be more likely to 
omit necessary medical items, lowering medical service quality. Therefore, a system of clinical 





Beijing University People's Hospital is among the early reform testing spots. In tackling the medical 
quality issues, the hospital set up a performance examination mechanism involving 88 quality 
control points before, during, and after medical procedures. The hospital intends to gradually 
separate physician compensation from medical cost, using the quality control mechanism to 
reduce over-prescription or low-quality care. People’s Hospital also hopes the new system will 
encourage physicians to accept patients with difficult diseases, to demonstrate the value of a 
university affiliated and tertiary hospital.  
 
“Medical Conglomerate” Experiment in Shanghai: A Multi-level Solution to the Accessibility Problem?  
Source: Economic Observer 2011-05-21 
http://insurance.jrj.com.cn/2011/05/21140010023083.shtml 
 
Many people complain about the difficulty of getting medical services, while most community 
hospitals have few patients. To solve this problem, Shanghai began constructing medical consortia 
this year. In the Healthcare Reform Plan released on May 17th, experimenting and constructing 
medical consortium is one of the ten important tasks. 
 
The construction of a medical consortium cannot be isolated from other healthcare reforms. The 
core purpose of the consortium is to reallocate resources among different levels of medical 
institutions, facilitate better cooperation, and encourage patients to choose hospitals according to 
need.  
 
Ruijin-Luwan medical consortium was formed in January, consisting of 1 tertiary hospital, 2 
secondary hospitals and 4 community medical centers. Patients could first go to the community 
hospitals, and if needed, transfer to higher level hospitals. Patients will be able to see physicians 
close to home, transfer to a different provider easily if needed, and book appointments with 
specialized doctors in tertiary hospitals. At the same time, data sharing platform and professionals 
exchanging mechanism could also be constructed to reduce unnecessary checkups and improve 
patients’ experience. 
 
However, consortia have been faced with many difficulties, the main cause being citizens’ distrust 
of medical service quality at community medical centers. Experts believe the success of medical 
consortia depends on patients’ trust and satisfaction, which are currently lacking.  
 
At this experimental stage, management of medical consortium, cooperation, and profit sharing 
among hospitals in the consortium remain unresolved, and are still in many cases administered by 
the local government. There is still a long way to go in promoting medical consortium nationwide. 
 
Public Hospitals in Shenzhen Decouple with Government: the Establishment of Hospital 
Administration Committee  
Source: 21st Century Economic Reporter 2011-6-2 
http://news.ifeng.com/mainland/detail_2011_06/02/6772199_0.shtml 
 
On May 31, three public hospital reform plans were released in Shenzhen, with the guiding principle 
that public hospitals should do public good, and not operate in pursuit of profit or higher financial 
or professional gains. Under these reforms, the current hospital administrative ranking system will be 
abolished and replaced by the board of directors system. Once in place, each board will assume 
full financial and personnel responsibilities for the hospital under its supervision, including the hiring 
of hospital director and associate director.   
 
A city-wide public hospital management committee will be formed to represent the government in 
making managerial and operational decisions, such as unified resource allocation within all city 






The city’s Department of Health, originally providing oversight on public hospitals, will now only be 
responsible for constituting regulations and rules, formulating industry standards, evaluating 
performance, and setting entrance standards for hospital personnel.  
 
Under the proposed system, hospital board of directors will be responsible for individual hospital’s 
management, while the government-level management committee will be responsible for all 
public hospitals within Shenzhen. With this more divided and professional management system, the 
reformers hope to improve public hospitals’ efficiency and effectiveness.  
 
Jointown Pharmaceutical Collaborates with 360buy.com to Pioneer Internet Drug Selling  
Source: 21st Century Economic Reporter 2011-6-30 
http://finance.ifeng.com/news/20110630/4209043.shtml 
 
Although not officially confirmed, cooperation between Jointown Pharmaceutical Group Co., Ltd 
and 360buy.com online shopping might be on its way. As the largest private pharmaceutical 
company in China with a sales volume of ¥22 billion RMB in 2010, Jointown seeks to break into the 
online B2C (Business to Customer) business, currently only accounting for a small fraction of the 
company’s profit. 
 
According to Nie Linhai, the Deputy Director of the Department of Information Technology within 
the Ministry of Commerce, the bottleneck for pharmaceutical e-business lies in logistics. Although 
many provinces and cities have been pushing for pharmaceutical e-business development, no 
company has exceeded ¥100 million RMB in sales.  
 
Experts in the field point to the unique requirement of individualized, web-based medicine 
distribution. Since all drugs are controlled and tracked by their production lot number, there could 
be no mistake when dividing whole-sale drugs into individual orders, requiring extensive industry 
and drug knowledge. Using the current Jointown B2C platform as an example, the company 
normally provides wholesale drugs to downstream drug stores in large quantities, but has to break 
them down to single packages when fulfilling online individual orders. This process is very costly, and 
explains why Jointown has yet to turn a profit on their B2C platform. 
 
With all the complications in sight, the healthcare e-business still offers great potential as the future 
venue for pharmaceutical trade. The Ministry of Commerce has adopted some policies to 
encourage the development of e-business and reduce transaction cost, and has estimated that 
the market volume for healthcare e-business might reach 17.8 billion RMB in 2011, with a projected 
30% CAGR for the next five years.  
 
 
 
 
 
  
